What is the current IsoRay market capitalization?
The current market capitalization of IsoRay is 39.76 M USD.
IsoRay Market capitalization 2024
IsoRay Market capitalization
39.76 M USD
Ticker
ISR
ISIN
US46489V1044
WKN
A0MQNM
In 2024, IsoRay's market cap stood at 39.76 M USD, a -13.56% increase from the 45.99 M USD market cap in the previous year.
The IsoRay Market capitalization history
| YEAR | Market Capitalization (undefined USD) |
|---|---|
| 2022 | 0.05 |
| 2021 | 0.09 |
| 2020 | 0.04 |
| 2019 | 0.03 |
| 2018 | 0.03 |
| 2017 | 0.03 |
| 2016 | 0.04 |
| 2015 | 0.08 |
| 2014 | 0.08 |
| 2013 | 0.02 |
| 2012 | 0.02 |
| 2011 | 0.03 |
| 2010 | 0.03 |
| 2009 | 0.01 |
| 2008 | 0.02 |
| 2007 | 0.07 |
| 2006 | 0.06 |
| 2005 | 0.32 |
| 2004 | 0.63 |
| 2003 | 3.17 |
IsoRay Aktienanalyse
What does IsoRay do?
The company IsoRay Inc is a leading global company in the field of brachytherapy and specializes in the development of novel medical devices for the treatment of cancer. The company's history dates back to the 1980s when it was founded by a team of doctors and scientists. IsoRay Inc's business model is based on the research, development, and manufacturing of medical products used in the treatment of cancer. Brachytherapy is a particularly important focus. This involves a treatment method where radioactive seeds or sources are directly implanted into the tumor. The radiation destroys the cancer cells without damaging the surrounding tissue. IsoRay Inc's product range includes a variety of medical devices and accessories for conducting brachytherapy procedures. The company specializes in the development of high-tech products that enable precise and effective radiation therapy. This includes, for example, radioactive seeds that are directly implanted into the tumor or apparatuses that can selectively use radiation in specific structures of the body. A special focus of IsoRay Inc is computer-assisted planning of brachytherapy treatments. The tumor is precisely measured and the radiation sources are individually customized based on the data to achieve an optimal radiation dose. This planning is done using modern software and is an important factor for the successful treatment of cancer. In addition to research and development of medical products, IsoRay Inc also encompasses the production and distribution of these products. The company operates in more than 30 countries worldwide and collaborates closely with numerous clinics and practices to research and improve new technologies in the field of radiation therapy. One of IsoRay Inc's most well-known products is the "Cesium-131 Brachytherapy seed." This radioactive seed is particularly small and therefore ideal for targeted radiation therapy of tumors. It is used in almost all clinical areas worldwide and is considered particularly safe and effective. Other products of the company include the "Gladius™ Applicator Needle," a device for precise placement of radiation sources in tumors, as well as "Intraoperative Application Systems" that enable effective radiation therapy during surgery. Overall, IsoRay Inc is considered an innovative and successful company in the field of brachytherapy and radiation therapy. The constant development and improvement of its own products is a key factor for the company's success. High quality and close collaboration with research and practice are central to its operations. IsoRay ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring IsoRay's Market Capitalization
IsoRay's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of IsoRay's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
IsoRay's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in IsoRay’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about IsoRay stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like IsoRay.
How has the market capitalization of IsoRay developed in recent years?
The market capitalization of IsoRay has increased/decreased by -13.56% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of IsoRay?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of IsoRay?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of IsoRay have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does IsoRay pay?
Over the past 12 months, IsoRay paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IsoRay is expected to pay a dividend of 0 USD.
What is the dividend yield of IsoRay?
The current dividend yield of IsoRay is .
When does IsoRay pay dividends?
IsoRay pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of IsoRay?
IsoRay paid dividends every year for the past 0 years.
What is the dividend of IsoRay?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is IsoRay located?
IsoRay is assigned to the 'Health' sector.
Wann musste ich die Aktien von IsoRay kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of IsoRay from 9/22/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/22/2024.
When did IsoRay pay the last dividend?
The last dividend was paid out on 9/22/2024.
What was the dividend of IsoRay in the year 2023?
In the year 2023, IsoRay distributed 0 USD as dividends.
In which currency does IsoRay pay out the dividend?
The dividends of IsoRay are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von IsoRay
Our stock analysis for IsoRay Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IsoRay Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
